205 related articles for article (PubMed ID: 13679499)
21. Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.
Taimur S; Nader C; Lloyd-Travaglini C; Seldin DC; Sanchorawala V
Transpl Infect Dis; 2013 Apr; 15(2):187-94. PubMed ID: 23279695
[TBL] [Abstract][Full Text] [Related]
22. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.
Sanchorawala V; Wright DG; Quillen K; Finn KT; Dember LM; Berk JL; Doros G; Fisher C; Skinner M; Seldin DC
Bone Marrow Transplant; 2007 Sep; 40(6):557-62. PubMed ID: 17589534
[TBL] [Abstract][Full Text] [Related]
23. A case with acute renal failure and subsequent nephrotic syndrome.
Nonoguchi H; Kohda Y; Fukutomi R; Nakayama Y; Naruse M; Kitamura K; Inoue T; Nakanishi T; Tomita K
Ren Fail; 2009; 31(2):162-6. PubMed ID: 19212916
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
Perfetti V; Siena S; Palladini G; Bregni M; Di Nicola M; Obici L; Magni M; Brunetti L; Gianni AM; Merlini G
Haematologica; 2006 Dec; 91(12):1635-43. PubMed ID: 17145600
[TBL] [Abstract][Full Text] [Related]
25. [Advances in diagnosis and treatment of AL amyloidosis].
Zelichowski G; Lubas A; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):340-5. PubMed ID: 18634370
[TBL] [Abstract][Full Text] [Related]
26. Reversible paraparesis in multiple myeloma with renal failure.
Terrier B; Joly D; Ghez D; Knebelmann B; Fakhouri F; Hummel A
Nephrol Dial Transplant; 2006 May; 21(5):1439-40. PubMed ID: 16520348
[No Abstract] [Full Text] [Related]
27. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis.
Oran B; Malek K; Sanchorawala V; Wright DG; Quillen K; Finn KT; La Valley M; Skinner M; Seldin DC
Bone Marrow Transplant; 2005 Mar; 35(6):567-75. PubMed ID: 15665842
[TBL] [Abstract][Full Text] [Related]
28. Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome.
Mollee PN; Wechalekar AD; Pereira DL; Franke N; Reece D; Chen C; Stewart AK
Bone Marrow Transplant; 2004 Feb; 33(3):271-7. PubMed ID: 14647248
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of nephrotic syndrome due to systemic AL amyloidosis after autologous stem cell transplantation: renal response is an important therapeutic end point.
Akay OM; Sahin G; Kabukcuoglu S; Yalcin AU; Gulbas Z
Clin Nephrol; 2008 Apr; 69(4):294-7. PubMed ID: 18397705
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
Iyengar A; Karthik S; Kumar A; Biswas S; Phadke K
Indian Pediatr; 2006 Jan; 43(1):14-9. PubMed ID: 16465001
[TBL] [Abstract][Full Text] [Related]
31. [Long-term survival after autologous peripheral blood stem cell transplantation in a patient with primary AL amyloidosis complicating congestive heart failure].
Saito M; Hayashi T; Nojima M; Ikeda H; Tarasawa I; Yasui H; Ishida T; Adachi M; Imai K; Shinomura Y
Rinsho Ketsueki; 2007 Nov; 48(11):1478-83. PubMed ID: 18080505
[TBL] [Abstract][Full Text] [Related]
32. Nephrotic syndrome due to primary AL amyloidosis, successfully treated with VAD and subsequent high-dose melphalan followed by autologous peripheral blood stem cell transplantation.
Gono T; Matsuda M; Dohi N; Hoshi K; Tada T; Sakashita K; Koike K; Aizawa M; Ikeda S
Intern Med; 2003 Jan; 42(1):72-7. PubMed ID: 12583623
[TBL] [Abstract][Full Text] [Related]
33. Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients.
Rysavá R; Merta M; Spicka I; Tesar V
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v38-40. PubMed ID: 12817067
[TBL] [Abstract][Full Text] [Related]
34. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
Arranz R; Conde E; Grande C; Mateos MV; Gandarillas M; Albo C; Lahuerta JJ; Fernández-Rañada JM; Hernández MT; Alonso N; García Vela JA; Garzón S; Rodríguez J; Caballero D;
Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400
[TBL] [Abstract][Full Text] [Related]
35. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring.
Goldsmith YB; Liu J; Chou J; Hoffman J; Comenzo RL; Steingart RM
Am J Cardiol; 2009 Oct; 104(7):990-4. PubMed ID: 19766769
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of amyloidosis].
Wien TN
Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1397-400. PubMed ID: 18552901
[TBL] [Abstract][Full Text] [Related]
37. Steroid resistant nephrotic syndrome is sustained remission attainable.
Nammalwar BR; Vijaykumar M; Prahlad N; Jain DV
Indian Pediatr; 2006 Jan; 43(1):39-43. PubMed ID: 16465005
[TBL] [Abstract][Full Text] [Related]
38. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis.
Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A
Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.
Thieblemont C; Antal D; Lacotte-Thierry L; Delwail V; Espinouse D; Michallet AS; Traulle C; Bouafia-Sauvy F; Giraud C; Salles G; Guilhot F; Coiffier B
Cancer; 2005 Oct; 104(7):1434-41. PubMed ID: 16104036
[TBL] [Abstract][Full Text] [Related]
40. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation.
Sanada S; Ookawara S; Karube H; Shindo T; Goto T; Nakamichi T; Saito M; Matsubara M; Suzuki M
Am J Kidney Dis; 2006 Apr; 47(4):672-9. PubMed ID: 16564945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
